SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

B. Riley FBR Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $10

B. Riley FBR maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and lowers the price target from $12 to $10.

Benzinga · 05/15/2020 11:21

B. Riley FBR maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and lowers the price target from $12 to $10.